Ciamexon (Ciamexone) is a novel immunomodulator that has shown promising results in experimental models of autoimmune disease with little demonstrated cytotoxicity.Ciamexon can be used to study endocrine ophthalmopathies and diabetes mellitus, with slight improvement in ophthalmic disease following short-term administration.

β-Amyloid P Component (27 - 38), amide

三乙氧基辛基硅烷是一种有机改性硅烷，已发现其以正常胶束和反胶束的形式聚集。